Skip to main content
Equibles

GRFS · Grifols SA · Webcasts, Transcripts & Audio

Track GRFS — free

Use GRFS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GRFS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$7.31 +0.01 (+0.14%) At close · Oct 2
Rebalance outlook locked
Market Cap
$5.00B
Shares
680.58M
Volume · Oct 2 390.35K Avg daily vol (3M) 604.84K

Grifols SA Webcasts

Earnings calls, investor updates, investor days and conferences for Grifols SA (GRFS), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Earnings call
FY26 · Q2
2026-07-28
Grifols SA (GRFS) Q2 2026 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
Grifols SA (GRFS) Q1 2026 Earnings Call Transcript
Positive tone Albumin in China headwinds Egypt plasma platform and global sourcing optimization Alpha-1 and Specialty Proteins
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Grifols SA (GRFS) Q4 2025 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Grifols SA (GRFS) Q3 2025 Earnings Call Transcript
Positive tone Free cash flow generation Margin expansion and EBITDA Fibrinogen pipeline
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Grifols SA (GRFS) Q2 2025 Earnings Call Transcript
Confident tone Commercial growth / Biopharma momentum Free cash flow & deleveraging Pipeline execution & fibrinogen launch
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Grifols SA (GRFS) Q1 2025 Earnings Call Transcript
Positive tone Q1 2025 Financial Performance Albumin Market and Phasing Fibrinogen Launch
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Grifols SA (GRFS) Q1 2024 Earnings Call Transcript
Positive tone Free cash flow generation Debt management and deleveraging Biopharma and plasma business momentum
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Grifols SA (GRFS) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Grifols SA (GRFS) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Grifols SA (GRFS) Q2 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Grifols SA (GRFS) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Grifols SA (GRFS) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Grifols SA (GRFS) Q3 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–13 of 13 webcasts
Key facts CIK 1438569 CUSIP 398438408 13F (30d) 4 filings 4 filers Visit website Investor relations